At NewAmsterdam Pharma, we are advancing a new era of treatments for cardiovascular disease (CVD) and other lipid-related conditions. By prioritizing patients with unmet needs despite currently available therapies, we are working toward a reality where cardiovascular disease is no longer the #1 killer of people worldwide.
Timothy Llanos, PharmD
Senior Medical Science Liaison
NewAmsterdam Pharma B.V.
Email: timothy.llanos@NewAmsterdamPharma.com
Phone: (718)530-5287